在第三级IBD诊所的炎症性肠病患者中查骨质疏松症
Tamerik Urbisinov1, Daniel Lightowler1,2, Fiona Yeaman1,2
1University of Western Australia Crawley Western Australia Australia.
JGH open : an open access journal of gastroenterology and hepatology
|December 10, 2025
概括
澳大利亚炎症性肠病 (IBD) 患者的骨质疏松症查率很低,尽管风险很高. 很少有风险人群接受骨密度扫描,揭示了骨质疏松症和骨质疏松症的高发病率.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 患有炎症性肠病 (IBD) 的患者患骨质疏松症的风险较高.
- 国际研究表明IBD患者的骨质疏松症查率较低.
- 之前没有研究在澳大利亚IBD队列中调查骨质疏松症查.
研究的目的:
- 评估澳大利亚第三级IBD诊所在IBD患者中的骨质疏松症查率.
- 用全面的风险因素评估来评估查.
主要方法:
- 一项回顾性临床审计审查了252名IBD诊所名单中的患者记录.
- 应用了来自欧洲,英国和澳大利亚指南的综合查标准.
- 没有最新的查患者在2020/2021年被评估为双能X射线吸收计 (DEXA) 扫描资格.
主要成果:
- 分析了173名IBD患者;150人需要进行风险评估.
- 101名患者符合查标准,但在研究期间只有12人完成了DEXA扫描.
- 在35个DEXA扫描中,37%显示骨质疏松症,40%显示骨质疏松症,23%是正常的.
结论:
- 很少有风险IBD患者接受了推的DEXA扫描.
- 在完成的扫描中观察到骨矿物质密度下降的高患病率.
- 未来的努力应验证扩展的查标准,以改善风险人群的检测.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
614
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
614
Inflammatory Bowel Disease II: Crohn's Disease
915
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
915
Inflammatory Bowel Disease IV: Pharmacological Management
445
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
445
Inflammatory Bowel Disease I: Ulcerative Colitis
859
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
859
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
459
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
459
Inflammatory Bowel Disease V: Surgical Management
424
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
424

